| Great Lakes Caring 1530 West Market Street, Akron, OH, 44313 | |
| (880) 260-9835 |
News Archive
Etubics Corporation, a biopharmaceutical company developing next generation vector vaccines, has entered into Phase I trials at Duke University with its ETBX-011, a therapeutic vaccine candidate that is intended to treat Carcinoembryonic Antigen expressing cancers such as colorectal cancer. Etubics dosed its first patient yesterday. Etubics was recently granted clearance by the U.S. Food and Drug Administration for its Investigational New Drug application to begin studying ETBX-011 in humans.
Brandeis scientists have made groundbreaking advances in understanding how the regulations of a novel gene during the cell cycle can lead to a rare familial case of the early onset of Parkinson's disease.
Praxair China has installed its NCOOL™ cryogenic heat exchanger system at Shanghai The First Biochemical & Pharmaceutical Co., Ltd., an affiliate of Shanghai Pharmaceutical (Group) Ltd. This is the first liquid nitrogen supply contract that Praxair China has signed that employs Praxair's patented NCOOL cryogenic heat exchanger system in a pharmaceutical freeze dryer.
A recent study conducted by scientists from the Yokohama City University, Japan, has revealed that elevated alveolar endothelial injury markers in coronavirus disease 2019 (COVID-19) patients with acute respiratory distress syndrome (ARDS) are the main causative factors for alveolar barrier disruption. In COVID-19 patients with ARDS, endothelial injury persists for a longer time than epithelial injury.
› Verified 6 days ago
| Name | Great Lakes Caring |
|---|---|
| Location | 1530 West Market Street, Akron, Ohio |
| Hospice ID | 361634 |
| Category | Freestanding Hospice |
| Ownership Type | Proprietary - Corporation |
| Profit Type | FOR PROFIT |
| Accreditation Provider | Accreditation Commission for Health Care (ACHC) |
| SSA county code | 780 |
News Archive
Etubics Corporation, a biopharmaceutical company developing next generation vector vaccines, has entered into Phase I trials at Duke University with its ETBX-011, a therapeutic vaccine candidate that is intended to treat Carcinoembryonic Antigen expressing cancers such as colorectal cancer. Etubics dosed its first patient yesterday. Etubics was recently granted clearance by the U.S. Food and Drug Administration for its Investigational New Drug application to begin studying ETBX-011 in humans.
Brandeis scientists have made groundbreaking advances in understanding how the regulations of a novel gene during the cell cycle can lead to a rare familial case of the early onset of Parkinson's disease.
Praxair China has installed its NCOOL™ cryogenic heat exchanger system at Shanghai The First Biochemical & Pharmaceutical Co., Ltd., an affiliate of Shanghai Pharmaceutical (Group) Ltd. This is the first liquid nitrogen supply contract that Praxair China has signed that employs Praxair's patented NCOOL cryogenic heat exchanger system in a pharmaceutical freeze dryer.
A recent study conducted by scientists from the Yokohama City University, Japan, has revealed that elevated alveolar endothelial injury markers in coronavirus disease 2019 (COVID-19) patients with acute respiratory distress syndrome (ARDS) are the main causative factors for alveolar barrier disruption. In COVID-19 patients with ARDS, endothelial injury persists for a longer time than epithelial injury.
› Verified 6 days ago
| NPI Number | 1841351608 |
| Organization Name | Op Hospice-ohio |
| Address | 1530 West Market Street Akron, Ohio, 44313 |
| Phone Number | (330)864-5700 |
News Archive
Etubics Corporation, a biopharmaceutical company developing next generation vector vaccines, has entered into Phase I trials at Duke University with its ETBX-011, a therapeutic vaccine candidate that is intended to treat Carcinoembryonic Antigen expressing cancers such as colorectal cancer. Etubics dosed its first patient yesterday. Etubics was recently granted clearance by the U.S. Food and Drug Administration for its Investigational New Drug application to begin studying ETBX-011 in humans.
Brandeis scientists have made groundbreaking advances in understanding how the regulations of a novel gene during the cell cycle can lead to a rare familial case of the early onset of Parkinson's disease.
Praxair China has installed its NCOOL™ cryogenic heat exchanger system at Shanghai The First Biochemical & Pharmaceutical Co., Ltd., an affiliate of Shanghai Pharmaceutical (Group) Ltd. This is the first liquid nitrogen supply contract that Praxair China has signed that employs Praxair's patented NCOOL cryogenic heat exchanger system in a pharmaceutical freeze dryer.
A recent study conducted by scientists from the Yokohama City University, Japan, has revealed that elevated alveolar endothelial injury markers in coronavirus disease 2019 (COVID-19) patients with acute respiratory distress syndrome (ARDS) are the main causative factors for alveolar barrier disruption. In COVID-19 patients with ARDS, endothelial injury persists for a longer time than epithelial injury.
› Verified 6 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 100.0 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 99.8 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 99.1 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 98.8 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 100.0 | 97.3 |
| Patients who got timely treatment for shortness of breath | 99.6 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 98.8 | 93.3 |
News Archive
Etubics Corporation, a biopharmaceutical company developing next generation vector vaccines, has entered into Phase I trials at Duke University with its ETBX-011, a therapeutic vaccine candidate that is intended to treat Carcinoembryonic Antigen expressing cancers such as colorectal cancer. Etubics dosed its first patient yesterday. Etubics was recently granted clearance by the U.S. Food and Drug Administration for its Investigational New Drug application to begin studying ETBX-011 in humans.
Brandeis scientists have made groundbreaking advances in understanding how the regulations of a novel gene during the cell cycle can lead to a rare familial case of the early onset of Parkinson's disease.
Praxair China has installed its NCOOL™ cryogenic heat exchanger system at Shanghai The First Biochemical & Pharmaceutical Co., Ltd., an affiliate of Shanghai Pharmaceutical (Group) Ltd. This is the first liquid nitrogen supply contract that Praxair China has signed that employs Praxair's patented NCOOL cryogenic heat exchanger system in a pharmaceutical freeze dryer.
A recent study conducted by scientists from the Yokohama City University, Japan, has revealed that elevated alveolar endothelial injury markers in coronavirus disease 2019 (COVID-19) patients with acute respiratory distress syndrome (ARDS) are the main causative factors for alveolar barrier disruption. In COVID-19 patients with ARDS, endothelial injury persists for a longer time than epithelial injury.
› Verified 6 days ago
| Home Health Aides | 19.5 |
| Counselors | 3.5 |
| Licensed Practical or Vocational Nurses | 5.5 |
| Medical Social Workers | 4.5 |
| Registered Nurses | 23 |
| Other Personnel | 6.5 |
| Total Employees | 62.5 |
|---|
News Archive
Etubics Corporation, a biopharmaceutical company developing next generation vector vaccines, has entered into Phase I trials at Duke University with its ETBX-011, a therapeutic vaccine candidate that is intended to treat Carcinoembryonic Antigen expressing cancers such as colorectal cancer. Etubics dosed its first patient yesterday. Etubics was recently granted clearance by the U.S. Food and Drug Administration for its Investigational New Drug application to begin studying ETBX-011 in humans.
Brandeis scientists have made groundbreaking advances in understanding how the regulations of a novel gene during the cell cycle can lead to a rare familial case of the early onset of Parkinson's disease.
Praxair China has installed its NCOOL™ cryogenic heat exchanger system at Shanghai The First Biochemical & Pharmaceutical Co., Ltd., an affiliate of Shanghai Pharmaceutical (Group) Ltd. This is the first liquid nitrogen supply contract that Praxair China has signed that employs Praxair's patented NCOOL cryogenic heat exchanger system in a pharmaceutical freeze dryer.
A recent study conducted by scientists from the Yokohama City University, Japan, has revealed that elevated alveolar endothelial injury markers in coronavirus disease 2019 (COVID-19) patients with acute respiratory distress syndrome (ARDS) are the main causative factors for alveolar barrier disruption. In COVID-19 patients with ARDS, endothelial injury persists for a longer time than epithelial injury.
› Verified 6 days ago
| Hospice Of Visiting Nurse Service Location: 3358 Ridgewood Road, Akron, Ohio, 44333 Phone: (880) 260-9835 |
| Hospice Of Summa And Summa At Home Hospice Service Location: 1077 Gorge Blvd, Akron, Ohio, 44310 Phone: (880) 260-9835 |
| Great Lakes Caring Location: 1530 West Market Street, Akron, Ohio, 44313 Phone: (880) 260-9835 |
| Compassionate Care Hospice Location: 300 North Cleveland Massillon Rd, Ste 103, Akron, Ohio, 44333 Phone: (880) 260-9835 |